ValiRx (VAL) Competitors GBX 0.56 -0.04 (-6.67%) As of 07/3/2025 11:44 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock VAL vs. HNR, SUN, EOG, WRES, EQT, CRC, WEB, NBL, FTO, and TXOShould you be buying ValiRx stock or one of its competitors? The main competitors of ValiRx include Highlands Natural Resources (HNR), Surgical Innovations Group (SUN), Europa Oil & Gas (EOG), W Resources (WRES), EQTEC (EQT), Circle Property (CRC), Webis (WEB), 18564 (NBL.L) (NBL), 2059984 (FTO.L) (FTO), and 282082 (TXO.L) (TXO). These companies are all part of the "petroleum and natural gas" industry. ValiRx vs. Its Competitors Highlands Natural Resources Surgical Innovations Group Europa Oil & Gas W Resources EQTEC Circle Property Webis 18564 (NBL.L) 2059984 (FTO.L) 282082 (TXO.L) ValiRx (LON:VAL) and Highlands Natural Resources (LON:HNR) are both small-cap petroleum and natural gas companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations and risk. Which has higher valuation & earnings, VAL or HNR? Highlands Natural Resources has higher revenue and earnings than ValiRx. ValiRx is trading at a lower price-to-earnings ratio than Highlands Natural Resources, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioValiRx£27.78K76.53-£5.71M-£1.48-0.38Highlands Natural Resources£1.02M0.00N/A-£4.90N/A Does the media favor VAL or HNR? In the previous week, ValiRx's average media sentiment score of 0.00 equaled Highlands Natural Resources'average media sentiment score. Company Overall Sentiment ValiRx Neutral Highlands Natural Resources Neutral Is VAL or HNR more profitable? Highlands Natural Resources has a net margin of 0.00% compared to ValiRx's net margin of -20,554.01%. Highlands Natural Resources' return on equity of 0.00% beat ValiRx's return on equity.Company Net Margins Return on Equity Return on Assets ValiRx-20,554.01% -55.84% -35.98% Highlands Natural Resources N/A N/A N/A SummaryHighlands Natural Resources beats ValiRx on 4 of the 6 factors compared between the two stocks. Get ValiRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VAL and its competitors with MarketBeat's FREE daily newsletter. Email Address VAL vs. The Competition Export to ExcelMetricValiRxBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£2.13M£128.02M£5.50B£2.96BDividend Yield0.63%3.74%5.38%5.02%P/E Ratio-0.383.4227.60146.59Price / Sales76.534,204.64369.38240,167.53Price / Cash62.5013.1936.6327.97Price / Book0.2143.018.055.30Net Income-£5.71M-£92.79M£3.18B£5.90B7 Day Performance-4.76%2.66%2.82%0.92%1 Month Performance12.45%2.53%3.70%5.20%1 Year Performance-80.91%178.37%35.41%80.76% ValiRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VALValiRxN/AGBX 0.56-6.7%N/A-81.9%£2.13M£27.78K-0.385,450Gap DownHNRHighlands Natural ResourcesN/AN/AN/AN/A£6.95M£1.02M-0.9616Gap DownHigh Trading VolumeSUNSurgical Innovations GroupN/AGBX 0.65-7.0%N/A+67.1%£6.07M£12.54M-21.1180Gap UpHigh Trading VolumeEOGEuropa Oil & GasN/AGBX 0.54+2.1%N/A-42.2%£5.14M£3.57M-0.762,850Gap DownHigh Trading VolumeWRESW ResourcesN/AN/AN/AN/A£3.89M£3.47M-0.4366Gap DownEQTEQTECN/AGBX 0.65+3.5%N/A-64.2%£1.67M£3.85M-3.81740Positive NewsCRCCircle PropertyN/AN/AN/AN/A£1.02M£7.57M50.001,060Gap DownHigh Trading VolumeWEBWebisN/AN/AN/AN/A£157K£49.70M14.1350Gap DownNBL18564 (NBL.L)N/AN/AN/AN/A£0.00N/A0.002,330FTO2059984 (FTO.L)N/AN/AN/AN/A£0.00N/A0.00147,000TXO282082 (TXO.L)N/AN/AN/AN/A£0.00N/A0.00170 Related Companies and Tools Related Companies Highlands Natural Resources Alternatives Surgical Innovations Group Alternatives Europa Oil & Gas Alternatives W Resources Alternatives EQTEC Alternatives Circle Property Alternatives Webis Alternatives 18564 (NBL.L) Alternatives 2059984 (FTO.L) Alternatives 282082 (TXO.L) Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:VAL) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ValiRx plc Please log in to your account or sign up in order to add this asset to your watchlist. Share ValiRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
